The results suggested that AR may inhibit the development of lung cancer by reducing the p53 expression in the nucleus and promoting p53 expression in the cytoplasm, downregulating the level of p-Bcl-2 and promoting the autophagy inhibitory factor mTOR expression. The gene discussed is AR; the disease is lung carcinoma.